With greedy Greg out, maybe Junius will go back where he belongs, to Finance and that would leave the door open to hire a real CEO. I really don't want a sale right now, they have too much potential to sell in the low $20's. I had a feeling this job was not big enough for GG. Now, hire Tony Coles and get the ship turned around, $1BB to $10BB just like ONXX. IMGN probably has more potential than ONXX did when Coles took over, they have no real development, no platform.
someone on the IV board had mentioned that Greg registered to sell some shares recently, I did not see the filing. The best possible solution is to have a new CEO, CFO and to replace O'Leary IMO. I doubt Junius will consider a demotion to CFO, cut in pay and removal from the BOD, but that would be OK. The key is that we need to hire a proven biotech winner to turn around and lead. We don't need a Pien, insider deal. The CFO role is important, but they already have 3-4 Bus Dev pros, a CEO that was the CFO. We don't need another CFO diluting the shareholders with a large option package. I would be curious to know why? was he bored, was there a disagreement about financing? Greg had mentioned the potential for monetizing Kadcyla revs and then backed off, it was a terrible idea that never should have been mentioned on a cc, but they have cc foot in mouth disease. Was there a disagreement over strategy? Most importantly, what's coming next, offering, no offering, sale of the company, new CEO, new CFO, any more resignations and hopefully, no major issues. It could be exciting positive, negative and volatile. We need more info!